This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Mar 2;325(9):821-822.

doi: 10.1001/jama.2021.1114.

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

John P Moore¹, Paul A Offit²

Affiliations

Affiliations

¹ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York.
² Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 33507218
DOI: 10.1001/jama.2021.1114

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

John P Moore et al. JAMA. 2021.

. 2021 Mar 2;325(9):821-822.

doi: 10.1001/jama.2021.1114.

Authors

John P Moore¹, Paul A Offit²

Affiliations

¹ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York.
² Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 33507218
DOI: 10.1001/jama.2021.1114

No abstract available

PubMed Disclaimer

Similar articles

Neutralizing SARS-CoV-2.
Poeschla E. Poeschla E. Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496. Elife. 2020. PMID: 33320086 Free PMC article.
Intermittent viral shedding in respiratory samples of patients with SARS-CoV-2: observational analysis with infection control implications.
AlJishi JM, Al-Tawfiq JA. AlJishi JM, et al. J Hosp Infect. 2021 Jan;107:98-100. doi: 10.1016/j.jhin.2020.09.011. Epub 2020 Sep 10. J Hosp Infect. 2021. PMID: 32920017 Free PMC article. No abstract available.
COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.
van Oosterhout C, Hall N, Ly H, Tyler KM. van Oosterhout C, et al. Virulence. 2021 Dec;12(1):507-508. doi: 10.1080/21505594.2021.1877066. Virulence. 2021. PMID: 33494661 Free PMC article. No abstract available.
Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
Xia X. Xia X. Viruses. 2021 Jan 14;13(1):109. doi: 10.3390/v13010109. Viruses. 2021. PMID: 33466921 Free PMC article. Review.
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T, Yamashita A, Mizuki N, Okuda K, Shimada M. Ura T, et al. Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24. Vaccine. 2021. PMID: 33279318 Free PMC article. Review.

See all similar articles

Cited by

Comprehensive Analysis of SARS-CoV-2 Dynamics in Bangladesh: Infection Trends and Variants (2020-2023).
Begum MN, Tony SR, Jubair M, Alam MS, Karim Y, Patwary MH, Rahman S, Habib MT, Ahmed A, Hossain ME, Rahman MZ, Khan MH, Shirin T, Qadri F, Rahman M. Begum MN, et al. Viruses. 2024 Aug 7;16(8):1263. doi: 10.3390/v16081263. Viruses. 2024. PMID: 39205237 Free PMC article.
Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow.
Kumar DS, Prasanth K, Bhandari A, Kumar Jha V, Naveen A, Prasanna M. Kumar DS, et al. Cureus. 2024 May 10;16(5):e60015. doi: 10.7759/cureus.60015. eCollection 2024 May. Cureus. 2024. PMID: 38854201 Free PMC article. Review.
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Pérez P, Albericio G, Astorgano D, Flores S, Sánchez-Corzo C, Sánchez-Cordón PJ, Luczkowiak J, Delgado R, Casasnovas JM, Esteban M, García-Arriaza J. Pérez P, et al. Front Immunol. 2023 Dec 12;14:1264323. doi: 10.3389/fimmu.2023.1264323. eCollection 2023. Front Immunol. 2023. PMID: 38155964 Free PMC article.
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.
Li P, Kim Y, Dampalla CS, Nhat Nguyen H, Meyerholz DK, Johnson DK, Lovell S, Groutas WC, Perlman S, Chang K-O. Li P, et al. mBio. 2024 Feb 14;15(2):e0287823. doi: 10.1128/mbio.02878-23. Epub 2023 Dec 21. mBio. 2024. PMID: 38126789 Free PMC article.
Next-Generation Vaccines Against COVID-19 Variants: Beyond the Spike Protein.
Bonam SR, Hu H. Bonam SR, et al. Zoonoses (Burlingt). 2023;3(1):10.15212/zoonoses-2023-0003. doi: 10.15212/zoonoses-2023-0003. Epub 2023 Apr 19. Zoonoses (Burlingt). 2023. PMID: 38031548 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal